Pages that link to "Q24648045"
Jump to navigation
Jump to search
The following pages link to Structure and signalling in the IL-17 receptor family (Q24648045):
Displaying 50 items.
- Evolutionary divergence and functions of the human interleukin (IL) gene family (Q21245454) (← links)
- Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF) (Q24319867) (← links)
- The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases (Q24594675) (← links)
- Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A (Q24597173) (← links)
- The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings (Q24623195) (← links)
- IL-17RC: a partner in IL-17 signaling and beyond (Q24629783) (← links)
- Structural basis of receptor sharing by interleukin 17 cytokines (Q24650068) (← links)
- Secukinumab for rheumatology: development and its potential place in therapy (Q26738523) (← links)
- Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same? (Q26744032) (← links)
- The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity (Q26750673) (← links)
- Cytokine-Induced Modulation of Colorectal Cancer (Q26752374) (← links)
- The IL-17A G-197A and IL-17F 7488T/C polymorphisms are associated with increased risk of cancer in Asians: a meta-analysis (Q26786578) (← links)
- Interleukin 17-Mediated Host Defense against Candida albicans (Q26798127) (← links)
- NF-κB, the first quarter-century: remarkable progress and outstanding questions (Q26822516) (← links)
- Inflammation, immunity, and hypertensive end-organ damage (Q26827525) (← links)
- Janus kinase inhibitors in autoimmune diseases (Q26865446) (← links)
- Cell type- and stimulus-specific mechanisms for post-transcriptional control of neutrophil chemokine gene expression (Q27004287) (← links)
- Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy (Q27010562) (← links)
- NF-κB in inflammation and renal diseases (Q27021276) (← links)
- Antimicrobial proteins in intestine and inflammatory bowel diseases (Q27023239) (← links)
- IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression (Q27025620) (← links)
- Interleukin-17 and acute coronary syndrome (Q27025823) (← links)
- Targeting of interleukin-17 in the treatment of psoriasis (Q27026324) (← links)
- Extensive expression differences along porcine small intestine evidenced by transcriptome sequencing (Q27322647) (← links)
- Structure of the unique SEFIR domain from human interleukin 17 receptor A reveals a composite ligand-binding site containing a conserved α-helix for Act1 binding and IL-17 signaling (Q27683721) (← links)
- Crystal structures of interleukin 17A and its complex with IL-17 receptor A (Q27684681) (← links)
- Secukinumab: A New Treatment Option for Psoriatic Arthritis (Q28066204) (← links)
- The Role of Interleukin-17 in Lung Cancer (Q28066949) (← links)
- Role of Interleukin 17 in Lung Carcinogenesis and Lung Cancer Progression (Q28068177) (← links)
- Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases (Q28069350) (← links)
- Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases (Q28076496) (← links)
- Evolution of the IL17 receptor family in chordates: a new subfamily IL17REL (Q28242526) (← links)
- Cytokines in psoriasis (Q28255491) (← links)
- Endogenous modulators of inflammatory cell recruitment (Q28274305) (← links)
- IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail (Q28506505) (← links)
- The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (Q28553220) (← links)
- Neuroprotection effect of interleukin (IL)-17 secreted by reactive astrocytes is emerged from a high-level IL-17-containing environment during acute neuroinflammation (Q28565232) (← links)
- Involvement of interleukin-17A in pancreatic damage in rat experimental acute necrotizing pancreatitis (Q28573370) (← links)
- Macrophages participate in IL-17-mediated inflammation (Q28652293) (← links)
- Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosis (Q28740839) (← links)
- IL-17A/F-signaling does not contribute to the initial phase of mucosal inflammation triggered by S. Typhimurium (Q28748185) (← links)
- Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). (Q29417124) (← links)
- Neutrophil cell surface receptors and their intracellular signal transduction pathways. (Q30009577) (← links)
- Amitriptyline Usage Exacerbates the Immune Suppression Following Burn Injury (Q30370188) (← links)
- The role of Th1 and Th17 cells in glomerulonephritis (Q30487944) (← links)
- The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss (Q30513501) (← links)
- IL-17 and TNF-α sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation (Q30515381) (← links)
- IL-17A is implicated in lipopolysaccharide-induced neuroinflammation and cognitive impairment in aged rats via microglial activation (Q30664735) (← links)
- Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β-C/EBPβ pathway (Q30664773) (← links)
- Anti-IL-17 phase II data for psoriasis: A review (Q30760301) (← links)